Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ocular ethambutol toxicity.

Alex Melamud1, Gregory S Kosmorsky, Michael S Lee

  • 1Cole Eye Institute, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.

Mayo Clinic Proceedings
|November 7, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disruptive Innovation to the Field of Interventional Cardiology.

Interventional cardiology clinics·2022
Same author

Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma.

Blood·2022
Same author

Elite Female Athletes Demonstrate a Comparable Improvement in Midterm Patient-Reported Outcome Scores and Rate of Return to Sport Compared With Elite Male Athletes After Hip Arthroscopic Surgery: A Sex-Based Comparison in Professional and Collegiate Athletes.

The American journal of sports medicine·2022
Same author

Bilateral Simultaneous Nonarteritic Anterior Ischemic Optic Neuropathy: Demographics, Risk Factors, and Visual Outcomes.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2022
Same author

Red Desaturation Prevalence and Severity in Healthy Patients.

Neurology. Clinical practice·2022
Same author

High-Level Athletes With Borderline Hip Dysplasia Achieve Favorable Outcomes and Return to Sport Rates Following Primary Hip Arthroscopy: Minimum 5-Year Outcomes Comparison to a Propensity-Matched Control Group.

Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association·2022

Ethambutol can cause severe optic neuropathy, a serious side effect of tuberculosis treatment. This toxicity can lead to irreversible vision loss, even with monitoring.

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Infectious Diseases

Background:

  • Ethambutol is a primary antimicrobial agent for treating tuberculosis.
  • Ethambutol-induced optic neuropathy is typically considered uncommon and reversible.

Observation:

  • A 43-year-old male patient developed bilateral optic neuropathy symptoms during ethambutol therapy.
  • The patient's condition highlights a severe and unpredictable toxic effect.

Findings:

  • Ethambutol toxicity can manifest as optic neuropathy.
  • The neuropathy may be severe and irreversible, contrary to common medical understanding.
  • Ophthalmologic monitoring may not prevent vision loss.

Implications:

Related Experiment Videos

  • Clinicians should be aware of the potential for severe ethambutol optic neuropathy.
  • Patient monitoring protocols may need re-evaluation.
  • Further research into predicting and preventing ethambutol toxicity is warranted.